The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand

Aroonlug Lulitanond1, Chulapan Engchanil, Prajuab Chaimanee

  • 1Centre for Research and Development in Medical Diagnostic Laboratory 2, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.

Insights

We identified increasing rates of vancomycin-resistant Staphylococcus aureus (VRSA) in a Thai university hospital. This study highlights the emergence of VRSA and heterogeneous VRSA strains, necessitating vigilant monitoring.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Antimicrobial Resistance

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat.
  • Vancomycin remains a critical antibiotic for treating MRSA infections.
  • The emergence of vancomycin resistance in MRSA strains (VRSA) is a growing concern.

Purpose of the Study:

  • To determine the prevalence of vancomycin-resistant Staphylococcus aureus (VRSA) and heterogeneous VRSA strains.
  • To analyze trends in VRSA and heterogeneous VRSA isolation over time.
  • To report the first isolation of VRSA strains from patients in Thailand.

Main Methods:

  • Screening of MRSA strains isolated from a university hospital.
  • Phenotypic detection of vancomycin resistance.
  • Analysis of strain data from two distinct time periods (2002-2003 and 2006-2007).

Main Results:

  • Identified 4 (0.8%) heterogeneous VRSA strains in 2002-2003.
  • Identified 8 (2.2%) heterogeneous VRSA strains in 2006-2007, showing an increase.
  • Detected 3 (0.8%) VRSA strains in 2006-2007.
  • This marks the first report of VRSA strains in Thailand.

Conclusions:

  • The prevalence of heterogeneous VRSA and VRSA strains has increased over the study period.
  • The findings underscore the emergence of vancomycin resistance in S. aureus in Thailand.
  • Continuous surveillance for VRSA is crucial for effective infection control and treatment strategies.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...